C20orf118 Inhibitors

TBC/LysM-associated domain-containing 2, often abbreviated as TBC1D2 or TBC1D2B, is a protein that, as suggested by its name, contains a TBC (Tre-2/Bub2/Cdc16) domain and a LysM (Lysin motif) domain. The TBC domain is known to be involved in Rab GTPase activation, which is a critical component of intracellular vesicle trafficking and membrane transport processes. Rab GTPases act as molecular switches that cycle between active GTP-bound and inactive GDP-bound states, regulating various stages of vesicular transport.The LysM domain is commonly found in proteins associated with bacterial cell wall degradation and is known to bind peptidoglycan, a major component of bacterial cell walls. In eukaryotic proteins, LysM domains are thought to be involved in signaling events, especially in response to microbial components, suggesting a role in the immune response.

TBC1D2's specific function has been subject to research, and evidence suggests that it may play a role in the modulation of signal transduction pathways and in mediating immune responses. The protein could potentially be involved in recognizing bacterial components and influencing the Rab GTPase cycle, thereby affecting cellular trafficking events that are integral to immune responses, such as antigen presentation or cytokine secretion.Given its domain architecture, TBC1D2 may serve as a bridge between recognizing microbial components and eliciting an appropriate cellular response. This could involve the regulation of vesicle formation, transport, and fusion processes that are necessary for the proper functioning of immune cells, such as macrophages and dendritic cells.